400
Participants
Start Date
January 1, 2016
Primary Completion Date
December 31, 2021
Study Completion Date
March 31, 2024
biomarker screening
immunohistochemistry and in situ hybridization
Severance Hospital, Yonsei University Health System, Yonsei Cancer Center, Seoul
Yonsei University
OTHER